深市代表委员热议深化创业板改革：制度包容再升级 精准赋能新质生产力

Core Viewpoint - The China Securities Regulatory Commission (CSRC) is set to enhance the listing standards for the ChiNext board, aiming to support innovative enterprises in new consumption and modern service industries, thereby injecting stronger capital momentum into the cultivation of new productive forces [1][4]. Group 1: Reform and Impact - The reform of the ChiNext board is expected to improve the capital market's ability to serve technological innovation and the real economy, providing a more favorable environment for innovative enterprises [1][4]. - The introduction of more precise and inclusive listing standards is anticipated to alleviate financing difficulties for new business models and industries [1][2]. - The continuous enhancement of institutional inclusiveness is a key theme of the ChiNext board reform, allowing for a broader range of companies, including those with light assets and R&D-driven models, to access financing [2][3]. Group 2: Success Stories and Examples - Companies like Betta Pharmaceuticals have successfully utilized the ChiNext board's diverse financing channels to bring multiple new drugs to market, showcasing the board's role in supporting innovation [2]. - The ChiNext board's flexible standards have enabled firms like Maipu Medical to transition from organic growth to a dual growth strategy through capital operations [3]. - The reforms have allowed companies such as Zhifei Biological to optimize their debt structure and enhance R&D funding through various financial instruments [3]. Group 3: Future Outlook - The ongoing reforms are seen as a crucial step in implementing the new "National Nine Articles," which aims to refine institutional design and attract more high-quality innovative enterprises to the ChiNext board [4]. - The ChiNext board is positioned to play a vital role in fostering high-quality development for growth-oriented innovative enterprises, facilitating a high-level circulation of technology, capital, and the real economy [4].